Araştırma Makalesi
BibTex RIS Kaynak Göster

Yıl 2021, Cilt: 5 Sayı: 4, 322 - 326, 01.04.2021

Bedri Caner Kaya Yusuf Çekici Berna Kaya Ahmet Celik Hüseyin Avni Demir Nurdan Yılmaz

https://doi.org/10.28982/josam.869073
Cited By: 1

Öz

Kaynakça

  • 1. Nik Muhamad NA, Hawari R, Shafie H. A case report of aluminium phosphide poisoning. Med J Malaysia. 2016;71:213-4.
  • 2. Zhu H, Rhee JW, Cheng P, Waliany S, Chang A, Witteles RM, et al. Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response. Curr Cardiol Rep. 2020;22:32.
  • 3. Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020;20:533-4.
  • 4. Zhang S, Diao M, Yu W, Pei L, Lin Z, Chen D. Estimation of the reproductive number of novel coronavirus (COVID-19) and the probable outbreak size on the Diamond Princess cruise ship: A data-driven analysis. Int J Infect Dis. 2020;93:201-4.
  • 5. Kochi AN, Tagliari AP, Forleo GB, Fassini GM, Tondo C. Cardiac and arrhythmic complications in patients with COVID-19. J Cardiovasc Electrophysiol. 2020;31:1003-8.
  • 6. Aghagoli G, Gallo Marin B, Soliman LB, Sellke FW. Cardiac involvement in COVID-19 patients: Risk factors, predictors, and complications: A review. J Card Surg. 2020;35:1302-5.
  • 7. Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F, et al. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA Cardiol. 2020;5:802-10.
  • 8. Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020;46:846-8.
  • 9. Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, et al. Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020;5:811-8.
  • 10. Hu H, Ma F, Wei X, Fang Y. Coronavirus fulminant myocarditis saved with glucocorticoid and human immunoglobulin. Eur Heart J. 2021;42(2):206.
  • 11. Guan W-J, Ni Z-Y, Hu Y, Liang W-H, Ou C-Q, He J-X, et al. Clinical characteristics of 2019 novel coronavirus infection in China. Med Rxiv. 2020. doi:10.1101/2020.02.06.20020974
  • 12. Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol 2020;17:259-60.
  • 13. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020;323:1061-9.
  • 14. Lippi G, Lavie CJ, Sanchis-Gomar F. Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): Evidence from a meta-analysis. Prog Cardiovasc Dis. 2020;63:390-1.
  • 15. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054-62.
  • 16. Mercuro NJ, Yen CF, Shim DJ, Maher TR, Mccoy CM, Zimetbaum PJ, et al. Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020;5:1036-41.
  • 17. Barman HA, Atici A, Sahin I, Alici G, Aktas Tekin E, Baycan Ö F, et al. Prognostic significance of cardiac injury in COVID-19 patients with and without coronary artery disease. Coron Artery Dis. 2020. doi: 10.1097/MCA.0000000000000914.
  • 18. Luo W, Yu H, Gou J, Li X, Sun Y, Li J, et al. Clinical pathology of critical patient with novel coronavirus pneumonia (COVID-19). Preprints. 2020;2020:2020020407.
  • 19. Levi M, Hunt BJ. Thrombosis and coagulopathy in COVID-19: An illustrated review. Res Pract Thromb Haemost. 2020;4:744-51.
  • 20. Zengin S, Avcı S, Yılmaz S. Clinical and basic cardiovascular features of patients with COVID-19 admitted to a tertiary care center in Turkey. J Surg Med. 2020;4(5):367-70.
  • 21. Zhang L, Yan X, Fan Q, Liu H, Liu X, Liu Z, et al. D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19. J Thromb Haemost. 2020;18:1324-9.
  • 22. Kasper W, Geibel A, Tiede N, Hofmann T, Meinertz T, Just H. [Echocardiography in the diagnosis of lung embolism]. Herz. 1989;14:82-101.
  • 23. Santoso A, Pranata R, Wibowo A, Al-Farabi MJ, Huang I, Antariksa B. Cardiac injury is associated with mortality and critically ill pneumonia in COVID-19: A meta-analysis. Am J Emerg Med. 2020 Apr 19. doi: 10.1016/j.ajem.2020.04.052.

A prospective study on the relationship between COVID-19 disease progress and cardiovascular damage

Yıl 2021, Cilt: 5 Sayı: 4, 322 - 326, 01.04.2021

Bedri Caner Kaya Yusuf Çekici Berna Kaya Ahmet Celik Hüseyin Avni Demir Nurdan Yılmaz

https://doi.org/10.28982/josam.869073
Cited By: 1

Öz

Background/Aim: Covid-19 is a new coronavirus disease with high mortality that has reached all parts of the world. This study aimed to prospectively compare individual characteristics, echocardiographic findings, and laboratory findings in patients with Covid-19 according to the need for intensive care unit (ICU) admission and mortality.
Methods: In this single-center prospective cohort study, patients hospitalized with the diagnosis of Covid-19 between June and November 2020 were examined in terms of echocardiographic and laboratory results. Early in-hospital findings that might affect mortality, cardiac injury and thrombotic complications were evaluated and compared.
Results: A total of 214 patients who were hospitalized due to Covid-19 were included in our study, 80 (37.3%) of which needed hospitalization in the ICU and 134 (62.6%) of which did not. The mean ages of patients treated in the ICU unit and the ward were 69.5 (57.5-80.5) years and 40 (29-58) years, respectively (P<0.001). Among patients hospitalized in the ICU, mean Troponin T on Day 1 (27.12 ng / L, range: 10.48-70.51, P<0.001), mean Troponin T on Day 3 (31.5ng / L, range: 10.24 - 114.5, P<0.001) and mean D-dimer (2.84ng / L, range: 1.1-8.22, P<0.001) levels of those who died were significantly higher compared to survivors. These parameters were important markers of mortality along with right ventricular end-diastolic diameter (RVDD) (3.3 cm (2.8-3.7) P<001).
Conclusion: While cardiac damage and high D-dimer values suggest the possibility of pulmonary microembolism in those who need ICU hospitalization, the relationship between RVDD and mortality supports the possibility of pulmonary embolism.

Anahtar Kelimeler

covid-19 d-dimer cardiac damage ICU RVDD

Kaynakça

  • 1. Nik Muhamad NA, Hawari R, Shafie H. A case report of aluminium phosphide poisoning. Med J Malaysia. 2016;71:213-4.
  • 2. Zhu H, Rhee JW, Cheng P, Waliany S, Chang A, Witteles RM, et al. Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response. Curr Cardiol Rep. 2020;22:32.
  • 3. Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020;20:533-4.
  • 4. Zhang S, Diao M, Yu W, Pei L, Lin Z, Chen D. Estimation of the reproductive number of novel coronavirus (COVID-19) and the probable outbreak size on the Diamond Princess cruise ship: A data-driven analysis. Int J Infect Dis. 2020;93:201-4.
  • 5. Kochi AN, Tagliari AP, Forleo GB, Fassini GM, Tondo C. Cardiac and arrhythmic complications in patients with COVID-19. J Cardiovasc Electrophysiol. 2020;31:1003-8.
  • 6. Aghagoli G, Gallo Marin B, Soliman LB, Sellke FW. Cardiac involvement in COVID-19 patients: Risk factors, predictors, and complications: A review. J Card Surg. 2020;35:1302-5.
  • 7. Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F, et al. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA Cardiol. 2020;5:802-10.
  • 8. Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020;46:846-8.
  • 9. Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, et al. Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020;5:811-8.
  • 10. Hu H, Ma F, Wei X, Fang Y. Coronavirus fulminant myocarditis saved with glucocorticoid and human immunoglobulin. Eur Heart J. 2021;42(2):206.
  • 11. Guan W-J, Ni Z-Y, Hu Y, Liang W-H, Ou C-Q, He J-X, et al. Clinical characteristics of 2019 novel coronavirus infection in China. Med Rxiv. 2020. doi:10.1101/2020.02.06.20020974
  • 12. Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol 2020;17:259-60.
  • 13. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020;323:1061-9.
  • 14. Lippi G, Lavie CJ, Sanchis-Gomar F. Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): Evidence from a meta-analysis. Prog Cardiovasc Dis. 2020;63:390-1.
  • 15. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054-62.
  • 16. Mercuro NJ, Yen CF, Shim DJ, Maher TR, Mccoy CM, Zimetbaum PJ, et al. Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020;5:1036-41.
  • 17. Barman HA, Atici A, Sahin I, Alici G, Aktas Tekin E, Baycan Ö F, et al. Prognostic significance of cardiac injury in COVID-19 patients with and without coronary artery disease. Coron Artery Dis. 2020. doi: 10.1097/MCA.0000000000000914.
  • 18. Luo W, Yu H, Gou J, Li X, Sun Y, Li J, et al. Clinical pathology of critical patient with novel coronavirus pneumonia (COVID-19). Preprints. 2020;2020:2020020407.
  • 19. Levi M, Hunt BJ. Thrombosis and coagulopathy in COVID-19: An illustrated review. Res Pract Thromb Haemost. 2020;4:744-51.
  • 20. Zengin S, Avcı S, Yılmaz S. Clinical and basic cardiovascular features of patients with COVID-19 admitted to a tertiary care center in Turkey. J Surg Med. 2020;4(5):367-70.
  • 21. Zhang L, Yan X, Fan Q, Liu H, Liu X, Liu Z, et al. D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19. J Thromb Haemost. 2020;18:1324-9.
  • 22. Kasper W, Geibel A, Tiede N, Hofmann T, Meinertz T, Just H. [Echocardiography in the diagnosis of lung embolism]. Herz. 1989;14:82-101.
  • 23. Santoso A, Pranata R, Wibowo A, Al-Farabi MJ, Huang I, Antariksa B. Cardiac injury is associated with mortality and critically ill pneumonia in COVID-19: A meta-analysis. Am J Emerg Med. 2020 Apr 19. doi: 10.1016/j.ajem.2020.04.052.
Toplam 23 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Konular Kalp ve Damar Cerrahisi
Bölüm Araştırma makalesi
Yazarlar

Bedri Caner Kaya 0000-0002-7913-6423

Yusuf Çekici 0000-0002-4585-3707

Berna Kaya Bu kişi benim 0000-0001-6862-1899

Ahmet Celik Bu kişi benim 0000-0003-1321-2945

Hüseyin Avni Demir 0000-0003-2891-9345

Nurdan Yılmaz Bu kişi benim 0000-0002-7987-096X

Yayımlanma Tarihi 1 Nisan 2021
Yayımlandığı Sayı Yıl 2021 Cilt: 5 Sayı: 4

Kaynak Göster

APA Kaya, B. C., Çekici, Y., Kaya, B., Celik, A., vd. (2021). A prospective study on the relationship between COVID-19 disease progress and cardiovascular damage. Journal of Surgery and Medicine, 5(4), 322-326. https://doi.org/10.28982/josam.869073
AMA Kaya BC, Çekici Y, Kaya B, Celik A, Demir HA, Yılmaz N. A prospective study on the relationship between COVID-19 disease progress and cardiovascular damage. J Surg Med. Nisan 2021;5(4):322-326. doi:10.28982/josam.869073
Chicago Kaya, Bedri Caner, Yusuf Çekici, Berna Kaya, Ahmet Celik, Hüseyin Avni Demir, ve Nurdan Yılmaz. “A Prospective Study on the Relationship Between COVID-19 Disease Progress and Cardiovascular Damage”. Journal of Surgery and Medicine 5, sy. 4 (Nisan 2021): 322-26. https://doi.org/10.28982/josam.869073.
EndNote Kaya BC, Çekici Y, Kaya B, Celik A, Demir HA, Yılmaz N (01 Nisan 2021) A prospective study on the relationship between COVID-19 disease progress and cardiovascular damage. Journal of Surgery and Medicine 5 4 322–326.
IEEE B. C. Kaya, Y. Çekici, B. Kaya, A. Celik, H. A. Demir, ve N. Yılmaz, “A prospective study on the relationship between COVID-19 disease progress and cardiovascular damage”, J Surg Med, c. 5, sy. 4, ss. 322–326, 2021, doi: 10.28982/josam.869073.
ISNAD Kaya, Bedri Caner vd. “A Prospective Study on the Relationship Between COVID-19 Disease Progress and Cardiovascular Damage”. Journal of Surgery and Medicine 5/4 (Nisan 2021), 322-326. https://doi.org/10.28982/josam.869073.
JAMA Kaya BC, Çekici Y, Kaya B, Celik A, Demir HA, Yılmaz N. A prospective study on the relationship between COVID-19 disease progress and cardiovascular damage. J Surg Med. 2021;5:322–326.
MLA Kaya, Bedri Caner vd. “A Prospective Study on the Relationship Between COVID-19 Disease Progress and Cardiovascular Damage”. Journal of Surgery and Medicine, c. 5, sy. 4, 2021, ss. 322-6, doi:10.28982/josam.869073.
Vancouver Kaya BC, Çekici Y, Kaya B, Celik A, Demir HA, Yılmaz N. A prospective study on the relationship between COVID-19 disease progress and cardiovascular damage. J Surg Med. 2021;5(4):322-6.

Cited By

The impact of Covid-19 on ECG: A case-control study
Journal of Surgery and Medicine
Bedri Caner KAYA
https://doi.org/10.28982/josam.971819
 Kapak Resmi İndir